Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stem Cells and Development is Scopus-indexed (Q2, CiteScore 4), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1547-3287Verify ISSN ↗1557-8534Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 59 / 151 | 61st | Q2 |
| Developmental Biology | 47 / 78 | 40th | Q3 |
| Cell Biology | 208 / 289 | 28th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q2, CiteScore 4.
Stem Cells and Development is Q2 in Hematology (rank 59 of 151), Q3 in Developmental Biology (rank 47 of 78) and Q3 in Cell Biology (rank 208 of 289), by CiteScore 2025.
Stem Cells and Development is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.532, quartile Q3, with an H-index of 142.
Stem Cells and Development is published by SAGE Publications Ltd. Its print ISSN is 1547-3287 and its online ISSN is 1557-8534.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Stem Cells and Development has an h-index of 154 and a 2-year mean of 2.36 citations per paper (OpenAlex). Its Scopus CiteScore is 4, quartile Q2. On 2-year citations it ranks #37 of 148 Scopus journals in Hematology.
Stem Cells and Development published 47 papers in 2025; its busiest recent year was 2018 with 153. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from China (30.8%), United States (20.6%) and Japan (14.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 21 retracted papers are recorded (5.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.